Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,240
Total Claims
$1.8M
Drug Cost
724
Beneficiaries
$2,551
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+81%
Cost per patient vs peers
$2,551 vs $1,411 avg
-6%
Brand preference vs peers
10.0% vs 10.6% avg
Brand vs Generic
Brand: 2,466 claims · $1.4M
Generic: 22,310 claims · $478K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 543 | $446K |
| Empagliflozin | 157 | $145K |
| Rivaroxaban | 160 | $118K |
| Apixaban | 141 | $106K |
| Diclofenac Epolamine | 254 | $99K |
| Linagliptin | 101 | $63K |
| Dapagliflozin Propanediol | 63 | $56K |
| Entecavir | 93 | $48K |
| Icosapent Ethyl | 95 | $47K |
| Omega-3 Acid Ethyl Esters | 480 | $46K |
| Insulin Glargine,hum.Rec.Anlog | 62 | $44K |
| Sitagliptin Phos/Metformin Hcl | 50 | $42K |
| Budesonide/Formoterol Fumarate | 57 | $31K |
| Losartan/Hydrochlorothiazide | 1,360 | $28K |
| Atorvastatin Calcium | 2,708 | $27K |
Prescribing Profile
Patient Profile
72
Avg Age
50%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data